Skip to content
Medical Health Aged Care

RACGP welcomes Victorian Parliament passing tax bill with amendments to protect bulk billing

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has welcomed the Parliament of Victoria passing omnibus tax legislation with amendments to protect bulk billing for Victorians.  

The State Taxation Further Amendment Bill 2024 passed the Senate yesterday with amendments exempting GPs from payroll tax on bulk billed services. In May, the Victorian Government committed to a retrospective exemption on payroll tax for independent GPs, meaning practices won’t be hit with a payroll tax bill that could shut them down. 

RACGP Victoria Chair Dr Anita Muñoz said: We welcome this legislation passing – it will help to protect bulk billing for Victorians. 

“This is a step forward to ensure everyone in Victoria can access affordable GP care, which is essential for people to stay healthy, and out of hospital.  

“Recently the RACGP welcomed Queensland becoming the first state to abolish payroll tax on GPs, with the newly elected Crisafulli Government making it a priority for the party’s first week in office.  

I encourage our government to take note, as this is the best solution to ensure affordable GP care and greater access to bulk billed services for patients.” 

General practices across Australia have always paid payroll tax on their employees, including receptionists, GPs in training and nurses, but it never applied to GPs because most are not employees, they work under independent agreements. This changed after a final ruling by the NSW Court of Appeal in 2023 deemed independent practitioners as employees for payroll tax purposes.    

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • COVID19, Medical Health Aged Care
  • 29/11/2024
  • 04:00
Pfizer Australia

Experts warn, don’t let COVID-19 disrupt your holiday plans

Survey shows COVID on thebackburner in the lead up to the higher risk season1 This summer, 9 in 10 Australians (91%) plan to visit loved ones, attend public venues, or travel by plane or public transport this season2 However, less than half (42%) say they would test for COVID-19 if symptomatic, and one in five (19%) admit they are likely to be in public even if they test positive2 A few simple steps can help keep your holiday on track and keep those at higher risk better protected from serious illness. SYDNEY, AUSTRALIA, 29 November 2024 – New results from…

  • Contains:
  • Medical Health Aged Care
  • 29/11/2024
  • 01:41
DEXIS

DEXIS Attends ADF, Showcases Award-Winning Solutions

QUAKERTOWN, PA / ACCESSWIRE / November 28, 2024 / The latest AI-powered launches from DEXIS enhance diagnostics and patient care. At ADF, DEXIS showcased its innovative product line, including the new intraoral scanners and imaging products. The conference took place November 26-30 at the Palais des Congrès de Paris in Porte Maillot, France. The company's comprehensive range of award-winning solutions covers a complete digital diagnostic workflow, from intraoral scanning and implant planning to sensors, CBCT, and imaging software. With an expanded portfolio and ecosystem, DEXIS Solutions is designed to accelerate workflows, increase productivity, and improve the patient experience."Our technology makes…

  • Medical Health Aged Care
  • 28/11/2024
  • 17:11
Galderma

Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis

Full results from the phase III OLYMPIA 1 trial evaluating the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis have been…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.